Effect of <i>GSTA1</i> Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians

Busulfan is widely used as a chemotherapy treatment before hematopoietic stem-cell transplantation (HSCT). However, the response of busulfan is highly variable and unpredictable, whereby the pharmacogenetic interference of glutathione <i>S</i>-transferase (GST) has strong evidence in Caucasians and...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ai-Hoc Nguyen, Mohitosh Biswas, Apichaya Puangpetch, Santirhat Prommas, Samart Pakakasama, Usanarat Anurathapan, Jiratha Rachanakul, Rattanaporn Sukprasong, Nutthan Nuntharadtanaphong, Nutcha Jongjitsook, Suradej Hongeng, Chonlaphat Sukasem
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-02-01
סדרה:	Pharmaceutics
נושאים:	busulfan hematopoietic stem-cell transplantation pharmacokinetics GST genetic polymorphisms pediatric Asians
גישה מקוונת:	https://www.mdpi.com/1999-4923/14/2/401
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!